Antimicrobial-drug Susceptibility of Human and Animal Salmonella Typhimurium, Minnesota, 1997–2003

Wedel, Stephanie D.; Bender, Jeffrey B.; Leano, Fe T.; Boxrud, David J.; Hedberg, Craig; Smith, Kirk E.

doi:10.3201/eid1112.050158

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Antimicrobial-drug Susceptibility of Human and Animal Salmonella Typhimurium, Minnesota, 1997–2003

Published Date:

Dec 2005

Publisher's site:

http://dx.doi.org/10.3201/eid1112.050158 New Site Icon

Source:

Emerg Infect Dis. 11(12):1899-1906.

[PDF-205.36 KB]

Details:

Alternative Title:

Emerg Infect Dis

Personal Author:

Wedel, Stephanie D. ; Bender, Jeffrey B. ; Leano, Fe T. ; Boxrud, David J. ; Hedberg, Craig ; ... More ▼

Description:

We compared antimicrobial resistance phenotypes and pulsed-field gel electrophoresis (PFGE) subtypes of 1,028 human and 716 animal Salmonella enterica serotype Typhimurium isolates from Minnesota from 1997 to 2003. Overall, 29% of human isolates were multidrug resistant. Predominant phenotypes included resistance to ampicillin, chloramphenicol or kanamycin, streptomycin, sulfisoxazole, and tetracycline (ACSSuT or AKSSuT). Most human multidrug-resistant isolates belonged to PFGE clonal group A, characterized by ACSSuT resistance (64%), or clonal group B, characterized by AKSSuT resistance (19%). Most animal isolates were from cattle (n = 358) or swine (n = 251). Eighty-one percent were multidrug resistant; of these, 54% were at least resistance phenotype ACSSuT, and 43% were at least AKSSuT. More than 80% of multidrug-resistant isolates had a clonal group A or B subtype. Resistance to ceftriaxone and nalidixic acid increased, primarily among clonal group A/ACSSuT isolates. Clonal group B/AKSSuT isolates decreased over time. These data support the hypothesis that food animals are the primary reservoir of multidrug-resistant S. Typhimurium.

Subject:

[+]

Document Type:

Journal Article

Funding:

U50/CCU511190-10/CC/ODCDC CDC HHS/United States ; U50/CCU519683-04-4/CC/ODCDC CDC HHS/United States ;

Collection(s):

Emerging Infectious Diseases
CDC Public Access

Main Document Checksum:

[+]

Supporting Files:

	05-0158.nxml	text/plain
	license.txt	text/plain
	05-0158-F1.gif	image/gif
	05-0158-F1.jpg	image/jpeg
	05-0158-F2.gif	image/gif
	05-0158-F2.jpg	image/jpeg
	05-0158-F3.gif	image/gif
	05-0158-F3.jpg	image/jpeg
	05-0158-F4.gif	image/gif
	05-0158-F4.jpg	image/jpeg

No Related Documents.

You May Also Like:

National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS) : human isolates final report, 2004

Corporate Authors:

National Antimicrobial Resistance Monitoring System--Enteric Bacteria (U.S.). National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Foodborne, Waterborne, and Environmental Diseases..

Published Date:

5/10/07

Description:

The National Antimicrobial Resistance Monitoring System (NARMS) for Enteric Bacteria is a collaboration among the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and U.S. Department of Agriculture (USDA). The pri...

File Type:

[PDF - 2.45 MB]
National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS) : human isolates final report, 2005

Corporate Authors:

National Antimicrobial Resistance Monitoring System--Enteric Bacteria (U.S.). National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Foodborne, Waterborne, and Environmental Diseases..

Published Date:

7/1/09

Description:

The National Antimicrobial Resistance Monitoring System (NARMS) for Enteric Bacteria is a collaboration among the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and U.S. Department of Agriculture (USDA). The pri...

File Type:

[PDF - 1.19 MB]
National Antimicrobial Resistance Monitoring System : Enteric Bacteria (NARMS) : human isolates final report, 2003

Corporate Authors:

National Antimicrobial Resistance Monitoring System--Enteric Bacteria (U.S.). National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Foodborne, Waterborne, and Environmental Diseases..

Published Date:

7/1/09

Description:

The National Antimicrobial Resistance Monitoring Sys- tem (NARMS) for Enteric Bacteria is a collaboration among the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and U.S. Department of Agriculture (USDA). CDC m...

File Type:

[PDF - 737.25 KB]
National Antimicrobial Resistance Monitoring System : enteric bacteria 1997 annual report

Corporate Authors:

National Center for Infectious Diseases (U.S.). Division of Bacterial and Mycotic Diseases. Foodborne and Diarrheal Diseases Branch.

Published Date:

August 13, 1999

Description:

In 1997, there were 1314 Salmonella isolates, 171 E. coli O157:H7 isolates, and 250 Campylobacter isolates submitted to the National Antimicrobial Resistance Monitoring System (NARMS). Thirty-four percent of Salmonella isolates were resistant to one ...

File Type:

[PDF - 937.52 KB]
National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS) : human isolates final report, 2006

Corporate Authors:

National Antimicrobial Resistance Monitoring System--Enteric Bacteria (U.S.). National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Foodborne, Waterborne, and Environmental Diseases..

Published Date:

7/9/09

Description:

The National Antimicrobial Resistance Monitoring System (NARMS) for Enteric Bacteria is a collaboration among the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA-CVM), and U.S. Department of Agriculture (USDA). The...

File Type:

[PDF - 2.30 MB]